COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7284
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors ; day:15 ; month:2 ; year:2021 ; pages:1-11
European journal of epidemiology ; (15.2.2021), 1-11
- Urheber
-
Elliott, Joshua
Bodinier, Barbara
Whitaker, Matthew
Delpierre, Cyrille
Vermeulen, Roel
Tzoulaki, Ioanna
Elliott, Paul
Chadeau-Hyam, Marc
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10654-021-00722-y
- URN
-
urn:nbn:de:101:1-2021040419312612337159
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elliott, Joshua
- Bodinier, Barbara
- Whitaker, Matthew
- Delpierre, Cyrille
- Vermeulen, Roel
- Tzoulaki, Ioanna
- Elliott, Paul
- Chadeau-Hyam, Marc
- SpringerLink (Online service)
Ähnliche Objekte (12)
Is occupational physical activity associated with mortality in UK Biobank?
Vitamin D and COVID-19 infection and mortality in UK Biobank
Social connection and mortality in UK Biobank: a prospective cohort analysis
Association between circadian physical activity patterns and mortality in the UK Biobank
The role of obesity in mortality from digestive diseases in UK Biobank
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
UK Biobank’s cardiovascular magnetic resonance protocol
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
Is occupational physical activity associated with mortality in UK Biobank?
Vitamin D and COVID-19 infection and mortality in UK Biobank
Social connection and mortality in UK Biobank: a prospective cohort analysis
Association between circadian physical activity patterns and mortality in the UK Biobank
The role of obesity in mortality from digestive diseases in UK Biobank
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
UK Biobank’s cardiovascular magnetic resonance protocol
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
Is occupational physical activity associated with mortality in UK Biobank?
Vitamin D and COVID-19 infection and mortality in UK Biobank
Social connection and mortality in UK Biobank: a prospective cohort analysis
Association between circadian physical activity patterns and mortality in the UK Biobank
The role of obesity in mortality from digestive diseases in UK Biobank
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
UK Biobank’s cardiovascular magnetic resonance protocol